Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ) soared at $1.73, a gain of 45.4%. On Mon, Jul 25, 2022, TNXP:NASDAQ touched a New 2-Week High of $1.73. The stock appeared on our News Catalysts scanner on Mon, Jul 25, 2022 at 12:27 PM in the 'MISCELLANEOUS' category. From Mon, Jul 11, 2022, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Mar 03, 2022 at $11.52 with a volume of 12M+.
About Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ)
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
Top 10 Gainers:
- Redbox Entertainment Inc. (RDBX:NASDAQ), 81.97%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 62.48%
- Nano Labs Ltd (NA:NASDAQ), 55.52%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 45.38%
- Koss Corporation (KOSS:NASDAQ), 45.27%
- Infrastructure and Energy Alternatives, Inc. (IEA:NASDAQ), 31.83%
- FaZe Holdings Inc. (FAZE:NASDAQ), 29.65%
- NuCana plc (NCNA:NASDAQ), 29.36%
- OPAL Fuels Inc. (OPAL:NASDAQ), 28.75%
- Borr Drilling Limited (BORR:NYSE), 20.38%